MENU
+Compare
FZMD
Stock ticker: OTC
AS OF
Jul 18 closing price
Price
$0.10
Change
+$0.03 (+42.86%)
Capitalization
5.99M

FZMD Fuse Medical, Inc. Forecast, Technical & Fundamental Analysis

Fuse Medical Inc is a y is a manufacturer, distributor, and wholesaler of medical device implants, offering a broad portfolio of orthopedic implants and biologics... Show more

FZMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for FZMD with price predictions
Jul 25, 2025

FZMD in upward trend: 10-day moving average crossed above 50-day moving average on July 02, 2025

The 10-day moving average for FZMD crossed bullishly above the 50-day moving average on July 02, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 19 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for FZMD just turned positive on July 18, 2025. Looking at past instances where FZMD's MACD turned positive, the stock continued to rise in of 50 cases over the following month. The odds of a continued upward trend are .

FZMD moved above its 50-day moving average on July 02, 2025 date and that indicates a change from a downward trend to an upward trend.

The Aroon Indicator entered an Uptrend today. In of 67 cases where FZMD Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The RSI Indicator demonstrates that the ticker has stayed in the overbought zone for 5 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 3 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

The 50-day moving average for FZMD moved below the 200-day moving average on June 26, 2025. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. FZMD’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.000) is normal, around the industry mean (24.694). P/E Ratio (1.735) is within average values for comparable stocks, (77.706). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (5.667). Dividend Yield (0.000) settles around the average of (0.018) among similar stocks. P/S Ratio (0.349) is also within normal values, averaging (43.573).

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. FZMD’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 90, placing this stock worse than average.

View a ticker or compare two or three
FZMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
N/A
Address
1565 N. Central Expressway
Phone
+1 469 862-3030
Employees
31
Web
https://www.fusemedical.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NSSC30.420.72
+2.42%
NAPCO Security Technologies
HYFM4.600.06
+1.32%
Hydrofarm Holdings Group Inc.
COST935.481.68
+0.18%
Costco Wholesale Corp
PSTL14.39-0.08
-0.55%
Postal Realty Trust
RMBS62.85-1.36
-2.12%
Rambus

FZMD and Stocks

Correlation & Price change

A.I.dvisor tells us that FZMD and HOCPF have been poorly correlated (+11% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that FZMD and HOCPF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FZMD
1D Price
Change %
FZMD100%
N/A
HOCPF - FZMD
11%
Poorly correlated
N/A
ESLOY - FZMD
9%
Poorly correlated
+1.16%
DSRLF - FZMD
8%
Poorly correlated
N/A
ECIA - FZMD
8%
Poorly correlated
N/A
EKTAY - FZMD
6%
Poorly correlated
+0.78%
More